A series of 7 unclassified uterine neoplasms expressing S100 and SOX10, lacking gene fusions and harboring an activating ERBB2 (HER2) mutation at codon 777 were presented in an abstract form at the USCAP annual meeting (Los Angeles, 2023) [14]. This evidence concerns the gene SOX10 and tumor of uterus.